Our qRT-PCR analyses further substantiate and corroborate these findings revealing that IDO-1 expression in glioma cells was significantly up-regulated after 24 hours of IFN-γ stimulation compared to unstimulated glioma cells. The gene discussed is IFNG; the disease is central nervous system cancer.